July 23, 2014 4:49 AM ET

Pharmaceuticals

Company Overview of DSM Pharmaceuticals, Inc.

Company Overview

DSM Pharmaceuticals, Inc. provides custom manufacturing services to the pharmaceutical and biopharmaceutical industries. It offers a range of manufacturing services in the areas of steriles, and orals and topicals, including dose form manufacturing, scheduled drugs, clinical manufacturing, fill finish manufacturing, aseptic filling, terminal sterilization, cold storage, ampoules, vials, and lyophilization. The company was formerly known as Catalytica Pharmaceuticals, Inc. and changed its name to DSM Pharmaceuticals, Inc. in December 2001. The company was incorporated in 1994 and is based in Greenville, North Carolina. DSM Pharmaceuticals, Inc. operates as a subsidiary of DSM Pharmaceutical P...

5900 Martin Luther King Jr. Highway

Greenville, NC 27834-8628

United States

Founded in 1994

Phone:

252-758-3436

Fax:

252-707-2046

Key Executives for DSM Pharmaceuticals, Inc.

Chief Executive Officer and President
Vice President of Business Management-Sterile Ctm And Cytotoxic Business
Chairman of Managing Board
Age: 66
Deputy Chairman of Managing Board
Age: 65
Member of Managing Board
Age: 55
Compensation as of Fiscal Year 2014.

DSM Pharmaceuticals, Inc. Key Developments

Discovery Laboratories Inc. Enters Master Services Agreement with DSM Pharmaceuticals, Inc

On October 24, 2013, Discovery Laboratories entered into a Master Services Agreement with DSM Pharmaceuticals, Inc. DSM is a contract manufacturing organization (CMO) with experience in the manufacture of lyophilized products and with whom the Company has completed a technology transfer of its lyophilized KL4 surfactant manufacturing process. The Agreement is intended to support further development and manufacture of the Company’s lyophilized KL4 surfactant for the Company’s pipeline programs, primarily AEROSURF. Pursuant to the Agreement, DSM will perform certain development and manufacturing activities relating to the Product as may be requested by the company and as may be agreed by the parties in one or more statements of work. Such activities could include but are not limited to equipment procurement and installation, validation master planning, regulatory support, quality assurance support, manufacture of engineering lots and development lots to support the Company’s preclinical, clinical, research and development activities, potential scale-up activities and potential manufacture of process validation lots.

DSM Pharmaceuticals, Inc. Signs Master Supply Agreement with Eisai Inc

DSM Pharmaceuticals, Inc. announced the signing of a 3 year master supply agreement with Eisai Inc. for the production of sterile products. The agreement covers the production of eribulin mesylate as well as other developmental drugs. The are delighted to be working with Eisai under a long-term agreement to serve markets globally for important human health treatments, bringing expertise and reliability in sterile injectables and worldwide regulatory record to ensure market supply. DSM will be a supplier for eribulin mesylate to the US market. Commercial production is anticipated to start in early 2013. It has been an honor to work with Eisai through the launch into commercial supply of eribulin mesylate and to continue to support the development of other products. Combining the expertise of Eisai in developing innovative medicines with DSM's strength in Good Manufacturing Practices (GMP), and supply chain management will provide critical high quality treatments for patients. DSM operates a 1.5 million square foot finished dosage facility in Greenville, North Carolina, USA, with a broad range of capabilities in aseptic filling of liquid and freeze-dried cytotoxic and non-cytotoxic steriles, the manufacture of tablets and capsules, pharmaceutical development services, and clinical trial materials manufacturing for solid and injectable forms, and holds a range of regulatory approvals including the production of scheduled drugs.

DSM Pharmaceuticals, Inc. Presents at BioPharm America 2012, Sep-19-2012

DSM Pharmaceuticals, Inc. Presents at BioPharm America 2012, Sep-19-2012 . Venue: Westin Boston Waterfront Hotel, 425 Summer Street, Boston, MA 02210, United States.

Similar Private Companies By Industry

Company Name Region
Enzo Therapeutics, Inc. United States
Amgen Fremont Inc. United States
Zurex Pharma, Inc. United States
Abeille Pharmaceuticals, Inc. United States
Pathfinder Management, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DSM Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.